Related Experiment Videos
[Recent progress in AT1 and AT2 receptor research].
1Department of Medical Biochemistry, Ehime University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 26, 2002
Summary
The AT2 receptor, often downregulated in adults but re-expressed in disease, antagonizes AT1 receptors. Stimulating AT2 receptors aids cardiovascular remodeling, particularly with AT1 receptor blockade.
Area of Science:
- Cardiovascular Physiology
- Renal Physiology
- Molecular Biology
Context:
- The renin-angiotensin system (RAS) plays a critical role in cardiovascular and renal homeostasis.
- Angiotensin II type 1 (AT1) and type 2 (AT2) receptors exhibit antagonistic functions.
- AT2 receptor expression is high in fetal tissues, low in adults, but upregulated during pathological conditions like vascular injury.
Purpose:
- To investigate the role of AT2 receptor in cardiovascular remodeling.
- To elucidate the interplay between AT1 and AT2 receptor signaling.
- To evaluate the therapeutic potential of modulating AT2 receptor activity.
Summary:
- AT1 and AT2 receptors demonstrate mutual antagonism.
- Co-stimulation of AT1 and AT2 receptors leads to premature termination of AT1-mediated cell growth signals by AT2.
- In AT2 receptor null mice, angiotensin II stimulation of the uninhibited AT2 receptor is crucial for Angiotensin Receptor Blocker (ARB)-mediated cardiovascular remodeling improvements.
Impact:
- Selective AT1 receptor blockade combined with AT2 receptor stimulation may offer a novel therapeutic strategy for cardiovascular diseases.
- Understanding AT2 receptor function is vital for developing treatments for cardiovascular and renal pathologies.
- This research highlights the importance of the AT2 receptor in mitigating pathological remodeling processes.